Compare McKesson Corporation (MCK) vs Star Bulk Carriers Corp (SBLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Star Bulk Carriers Corp — how do they compare? McKesson Corporation trades at $828.8 (market cap $97.35B), while Star Bulk Carriers Corp trades at $26.43 (market cap $2.91B). The key difference: McKesson Corporation is far larger — about 33.5× Star Bulk Carriers Corp's market cap, and Star Bulk Carriers Corp pays the higher dividend (3.95%). Which is the better fit depends on your goals.
| MCK | SBLK | |
|---|---|---|
Market Cap | $97.35B | $2.91B |
Sector | Health | Industrials |
52-Week High | $995.69 | $28.21 |
52-Week Low | $659.01 | $16.79 |
Enterprise Value | $101.98B | $3.61B |
Dividend Yield | 0.39% | 3.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.
The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.
Star Bulk Carriers (SBLK) trades at $26.09, up 4.78% in the last session. Technical indicators are bearish, but fundamentals show strength with a P/E of 19.92 and net income margin of 13.01%. Recent earnings beat expectations in Q4 2025 and Q1 2026, with Q2 2026 EPS expected at $0.96. The company maintains a healthy balance sheet and pays dividends, including a recent $0.50 per share distribution.
Outlook is cautiously optimistic due to strong dry bulk rates and fleet modernization driving cash flow. Risks include shipping rate volatility and macroeconomic pressures. Analyst consensus is bullish with 58.34% buy ratings, but technical weakness suggests near-term caution. The stock offers value with a 10%+ dividend yield potential if rates sustain.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Star Bulk Carriers Corp
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →
